![](/img/cover-not-exists.png)
Safety and efficacy of first-line treatment with doxorubicin, cyclophosphamide, bortezomib, dexamethasone and lenalidomide (ACVDL) in newly diagnosed multiple myeloma patients of all ages
Andersen, K.T., Hinge, M., Segel, E., Ormstrup, T., Holdgaard, P., Joergensen, H.B., Pallisgaard, N., Kerndrup, G., Plesner, T.Volume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.07.346
Date:
September, 2015
File:
PDF, 62 KB
english, 2015